Stability of Multi-Parametric Prostate MRI Radiomic Features to Variations in Segmentation.

multi-parametric MRI prostate radiomics

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
22 Jul 2023
Historique:
received: 11 05 2023
revised: 13 07 2023
accepted: 18 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Stability analysis remains a fundamental step in developing a successful imaging biomarker to personalize oncological strategies. This study proposes an in silico contour generation method for simulating segmentation variations to identify stable radiomic features. Ground-truth annotation provided for the whole prostate gland on the multi-parametric MRI sequences (T2w, ADC, and SUB-DCE) were perturbed to mimic segmentation differences observed among human annotators. In total, we generated 15 synthetic contours for a given image-segmentation pair. One thousand two hundred twenty-four unfiltered/filtered radiomic features were extracted applying Pyradiomics, followed by stability assessment using ICC(1,1). Stable features identified in the internal population were then compared with an external population to discover and report robust features. Finally, we also investigated the impact of a wide range of filtering strategies on the stability of features. The percentage of unfiltered (filtered) features that remained robust subjected to segmentation variations were T2w-36% (81%), ADC-36% (94%), and SUB-43% (93%). Our findings suggest that segmentation variations can significantly impact radiomic feature stability but can be mitigated by including pre-filtering strategies as part of the feature extraction pipeline.

Identifiants

pubmed: 37511785
pii: jpm13071172
doi: 10.3390/jpm13071172
pmc: PMC10381192
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Insights Imaging. 2020 Aug 12;11(1):91
pubmed: 32785796
Sci Rep. 2021 Jan 21;11(1):2055
pubmed: 33479392
Abdom Radiol (NY). 2016 May;41(5):844-53
pubmed: 27193787
Eur Urol. 2019 May;75(5):712-720
pubmed: 30509763
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):E6265-73
pubmed: 26578786
Sci Rep. 2017 Apr 3;7(1):588
pubmed: 28373718
Tomography. 2016 Mar;2(1):56-66
pubmed: 27200418
Sci Rep. 2021 Jun 21;11(1):12917
pubmed: 34155265
Sci Rep. 2019 Mar 18;9(1):4800
pubmed: 30886309
Med Phys. 2020 Apr;47(4):1680-1691
pubmed: 31971614
AJR Am J Roentgenol. 2017 Jan;208(1):131-139
pubmed: 27726415
Eur Urol. 2017 Apr;71(4):648-655
pubmed: 27349615
Invest Radiol. 2019 Apr;54(4):221-228
pubmed: 30433891
Phys Eng Sci Med. 2020 Jun;43(2):517-524
pubmed: 32524436
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
Sci Rep. 2019 Jan 24;9(1):614
pubmed: 30679599
Eur Radiol. 2022 Jan;32(1):680-689
pubmed: 34255161
Front Oncol. 2020 Jun 16;10:940
pubmed: 32612953
J Nucl Med. 2011 Mar;52(3):369-78
pubmed: 21321270
PLoS One. 2021 May 7;16(5):e0251147
pubmed: 33961646
Transl Oncol. 2014 Feb 01;7(1):72-87
pubmed: 24772210
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1238-47
pubmed: 17336224
J Urol. 2015 Jan;193(1):87-94
pubmed: 25079939
BJU Int. 2018 Dec;122(6):946-958
pubmed: 29679430
J Magn Reson Imaging. 2020 Oct;52(4):1239-1248
pubmed: 32181985
Sci Rep. 2020 Jul 29;10(1):12688
pubmed: 32728098
Sci Data. 2018 Dec 04;5:180281
pubmed: 30512014
Invest Radiol. 2017 Sep;52(9):538-546
pubmed: 28463931
J Magn Reson Imaging. 2019 Mar;49(3):875-884
pubmed: 30230108
Eur Urol. 2019 Sep;76(3):340-351
pubmed: 30898406
Phys Med. 2020 Mar;71:71-81
pubmed: 32092688
Cancer. 2016 Mar 15;122(6):884-92
pubmed: 26749141
Br J Radiol. 2022 Mar 01;95(1131):20210842
pubmed: 34538077
N Engl J Med. 2021 Sep 2;385(10):908-920
pubmed: 34237810
Med Phys. 2019 Nov;46(11):5116-5123
pubmed: 31539450
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):57-66
pubmed: 9989514
Can Urol Assoc J. 2018 Aug;12(8):270-275
pubmed: 30139428
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
PLoS One. 2016 Oct 14;11(10):e0164924
pubmed: 27741289
Comput Methods Programs Biomed. 2021 Sep;208:106236
pubmed: 34311413
J Big Data. 2021;8(1):101
pubmed: 34306963
BJU Int. 2018 Jul;122(1):59-65
pubmed: 29438586
Radiology. 2019 Aug;292(2):365-373
pubmed: 31210613
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1923-9
pubmed: 21514071
Eur Urol. 2020 Oct;78(4):512-514
pubmed: 32416975
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Med Phys. 2018 Jul;45(7):3076-3085
pubmed: 29663411
Sci Rep. 2019 Jul 1;9(1):9441
pubmed: 31263116
Tomography. 2016 Dec;2(4):430-437
pubmed: 28149958
J Magn Reson Imaging. 2018 Feb 22;:
pubmed: 29469937
Urol Oncol. 2022 Apr;40(4):161.e1-161.e7
pubmed: 34465541
Cancer Res. 2017 Jul 15;77(14):3922-3930
pubmed: 28566328
Med Phys. 2020 Jul;47(7):3054-3063
pubmed: 32277703
Eur Urol. 2015 Apr;67(4):627-36
pubmed: 25511988
Nat Rev Clin Oncol. 2014 Jun;11(6):346-53
pubmed: 24840072

Auteurs

Sithin Thulasi Seetha (S)

Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Department of Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University, 6211 LK Maastricht, The Netherlands.

Enrico Garanzini (E)

Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Chiara Tenconi (C)

Department of Medical Physics, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Department of Oncology and Hematooncology, Università degli Studi di Milano, 20133 Milan, Italy.

Cristina Marenghi (C)

Unit of Genito-Urinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Barbara Avuzzi (B)

Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Mario Catanzaro (M)

Department of Urology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Silvia Stagni (S)

Department of Urology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Sergio Villa (S)

Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Barbara Noris Chiorda (BN)

Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Fabio Badenchini (F)

Unit of Genito-Urinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Elena Bertocchi (E)

Unit of Genito-Urinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Sebastian Sanduleanu (S)

Department of Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University, 6211 LK Maastricht, The Netherlands.

Emanuele Pignoli (E)

Department of Medical Physics, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Giuseppe Procopio (G)

Unit of Genito-Urinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Riccardo Valdagni (R)

Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Department of Oncology and Hematooncology, Università degli Studi di Milano, 20133 Milan, Italy.

Tiziana Rancati (T)

Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Nicola Nicolai (N)

Department of Urology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Antonella Messina (A)

Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Classifications MeSH